Carrefour acquired Paulaur's pharmaceutical sugar pill core production line business

Harleysville, Philadelphia, U.S., January 18, 2016 - Calecon corporation announced the acquisition of Paulaur's pharmaceutical sucrose pill core line, a Cranbury, N.J., manufacturer of accessories focused on sucrose.
Paulaur's products complete the product line of Suglets® Sugar Spheres, further enhancing Calorcon's leading position as a global supplier of high-quality pharmaceutical pill cores and promoting the development of multiparticle preparations worldwide. The acquisition will ensure that pharmaceutical pill core products continue to be supplied to Paulaur's existing pharmaceutical and dietary supplement customers.
provide pharmaceutical and nutritional supplement manufacturers with pharmaceutical and nutritional supplements worldwide, particularly in the multi-particle and thin-film coating business. Because of its successful investments in rapid release, delayed and slow-release clospea, as well as in the multi-particle sector, Kalokang can today serve its customers with pill cores for pharmaceutical and nutritional supplements.
, General Manager of Carlyle's Prescription Formula Products, said:
In the industry, there is a great demand for suppliers who can continue to provide high-quality products, applications and formulation support. The acquisition is also a complement to Calordon's existing investment in manpower, productivity and structure, enhancing Calorcon's ability to provide best-in-class products and services to its pharmaceutical and nutritional supplement customers on an ongoing basis.
Mitchell Stefaniak, vice president and chief financial officer of Paulaur, also said: "Paulaur has decided to exit the global sucrose core of pharmaceutical and nutritional supplements, focusing on its fast-growing food and confectionery business. At the same time, we want to ensure that our customers in the pharmaceutical and nutritional supplements sector continue to use high-quality products with confidence. This time, we decided to sell this production line to Carrefour is also for our customers to find such an excellent supplier. Marty Hedman, chief executive
, also said that "this acquisition of Paulaur's pharmaceutical sucrose core business is an exciting strategic acquisition." Our initial announcement of this event in the new year also bodes well for the continued prosperity of the Carlecon business in the new year. Taking this agreement as an opportunity, Kalokang will expand its global business of medicinal sucrose pill cores and increase the global impact of sales channels and technical services.
, which offers a full range of products and services for solid formulation formulations, has been following the continued growth of multiparticle formulations, especially for the elderly and children. Through this agreement, Customers of Calecon and Paulaur can benefit from Calocon's products, technical services and support.about Kalokang
Kalokang is a leader in the development, supply and technical support of thin film coating systems, slow-release technologies and multi-functional pharmaceutical accessories in the global pharmaceutical industry. We are committed to providing quality pharmaceutical products and first-class value-added services to support the design, development and manufacture of solids. With our focus on market issues and technology development, our first-class product quality, unparalleled technical support, extensive regulatory assistance and reliable multi-faceted supply capabilities have earned calocon a reputation as the world's preferred pharmaceutical supplier. With 9 production sites, 19 technical service laboratories worldwide and more than 1,200 employees dedicated to customer support. (Kalekang)